The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer

Shiu-Jau Chen,Shao-Cheng Wang,Yuan-Chuan Chen

DOI: https://doi.org/10.3390/ijms222312836

IF: 5.6

2021-11-27

International Journal of Molecular Sciences

Abstract:Immunotherapy is a novel anti-cancer method which employs a different mechanism to conventional treatment. It has become a significant strategy because it provides a better or an alternative option for cancer patients. Recently, immunotherapy has been increasingly approved for the treatment of cancer; however, it has various limitations; for instance, it is only suitable for specific patients, the response rate is still low in most cases, etc. Colorectal cancer, lung cancer and pancreatic cancer are known as three major death-causing cancers in most countries. In this review, we discuss immunotherapeutic treatment for these three cancers, and consider the option, prospects and limitations of immunotherapy. The development of immunotherapy should focus on the discovery of biomarkers to screen suitable patients, new targets on tumors, neoadjuvant immunotherapy and the combination of immunotherapy with conventional therapeutic methods. We can expect that immunotherapy potentially will develop as one of the best therapies for patients with advanced cancer or poor responses to traditional methods.

biochemistry & molecular biology,chemistry, multidisciplinary